Text or WhatsApp Richard at (808) 600-9260
Lion crestHealthcareInvestmentBanking.com

Finding Healthcare Investors: PE, Family Offices, Strategics, VC, Physicians and Lenders

Healthcare capital comes from six sources: private equity, family offices, strategic buyers, venture capital and angels, physician investors and lenders. Match the source to the transaction. A control sale goes to PE or a strategic. A minority growth round or partial recap goes to a family office or physicians. Healthtech goes to VC. A cash-flow-backed expansion goes to a lender. The rest of this guide shows how to pick between them, where to find the names and how to compare the offers on one sheet.

Data current as of November 20, 2026. Each sourced figure links to its source document and names the population and period. Figures labeled our arithmetic are calculated from those sources.

Investors keep coming because the spending base keeps growing. The CMS National Health Expenditure fact sheet reports that US spending on physician and clinical services topped $1 trillion in 2024. CMS projects that category to grow 5.5% a year on average over 2025 to 2034. Your payer mix decides how much of that growth reaches your practice. In the same 2024 data, Medicare accounted for 21% of total health spending and private health insurance for 31%.

The 6 Investor Types Compared: Control, Capital Form and Horizon

Investor What they buy Control Horizon What sets the timeline Best fit Watch for
Private equity (platform or add-on) Majority equity, usually with seller rollover Majority and board Fixed fund life, exit by resale QoE, investment committee Scalable specialties with add-on runway Your rollover value depends on the next buyer
Family office Minority or majority equity, structured equity, some private debt Negotiable Set by the family for direct deals, by the vehicle for fund or SPV deals The office's own approval process Growth rounds, partial recaps, long holds Mandates and healthcare depth differ widely from office to office
Strategic (hospital system, large provider group, health plan) Full acquisition or employment model Full No fixed exit date, though strategics do divest units Committee and integration planning Practices that add market share or fill service lines You become an employee, and referral rules shape how physician pay is set
Venture capital and angels Minority preferred equity Board seat, protective provisions Fund life, exit by sale or IPO Partner meeting Healthtech, devices, diagnostics, biotech Liquidation preferences and dilution in each round
Physician investors Small minority checks pooled in a syndicate None individually Long, yield-focused Collecting many checks to a close ASCs, imaging, real estate, de novo sites Referral rules and securities offering rules
Lenders (bank, SBA, private credit) Senior or unitranche debt Covenants, guarantees Loan term Credit underwriting Stable EBITDA, acquisitions, dividend recaps A covenant breach shifts control to the lender

Start With Your Goal

Your goal Call first Call second Usually a poor fit
Full exit within a year PE platform in your specialty, hospital system Large provider group, health plan Physician syndicate, VC
Take some cash off the table and keep control Direct-investing family office Lender (dividend recap) Strategic
Fund new sites without giving up equity Bank or SBA lender Private credit, family office structured equity VC
Build an ASC, imaging center or real estate project Physician syndicate, family office Lender for the build-out VC
Scale a healthtech product Healthcare VC fund Corporate venture arm, family office Bank lender
Fix payer rates or administrative load Hospital system, PE platform with contracting scale Health plan Lender (capital alone does not change contracts)

Seven Questions Before You Build a List

The last question narrows the field fastest. In the AMA Policy Research Perspective, Physician Practice Characteristics in 2024, physicians who had sold their practices in the prior 10 years to a hospital, PE firm or insurer rated these reasons as important or very important:

Reason for selling (AMA 2024 survey, physicians who sold in the prior 10 years) Share rating it important or very important Investors that can address it, depending on buyer and terms
Better negotiate higher payment rates with payers 70.8% Hospital systems, large provider groups, PE platforms with contracting scale
Improve access to costly resources 64.9% Strategics, PE platforms, family offices, lenders
Better manage payers' regulatory and administrative requirements 63.6% Strategics, PE platforms with shared billing and compliance teams

Ownership alone does not change a payer contract. A larger owner helps only if its contracts cover your market and your practice moves onto them. Ask each buyer three questions. Which payer contracts do you hold in my market? Will my practice move onto them, and when? Which billing, credentialing and compliance functions will you take over? Family office equity and debt address the second reason only.

Where Independent Practices Still Sit: Specialty and Size

Buyer interest follows the remaining pool of independent physicians. The AMA press release on the 2024 Physician Practice Benchmark Survey reports that private practices now account for less than half of physicians in most specialties. The exceptions are surgical.

Specialty Share of physicians in private practice (AMA press release, 2024 survey)
Ophthalmology 70.4%
Orthopedic surgery 54.0%
Other surgical subspecialties 51.2%
Radiology 46.9%
Cardiology 30.7%

Size shapes the investor too. The AMA's 2024 report found that 49.2 percent of physicians in private practice work in practices with fewer than five physicians, and only 11.8 percent in practices of 50 or more. Groups that small are add-on candidates or debt borrowers. Few can anchor a new PE platform. Across all practice types, the same report puts the share of physicians in practices of 10 or fewer at 47.4 percent in 2024, down from 61.4 percent in 2012. In the AMA's words, it was "the first time this share has dipped below 50 percent."

Private Equity: 119 of 148 Tracked Outpatient Deals in 2025 Were Add-Ons

PE owns a small but rising share of physician practices. The AMA press release reports that 6.5 percent of physicians described their practice as PE-owned in 2024, up from about 4.5 percent in both 2020 and 2022. In the same survey, 34.5 percent described their practice as hospital-owned, about five times the PE share (our arithmetic: 34.5 ÷ 6.5 = 5.3).

Most of PE's position is recent. The AMA's 2024 report found that about 38 percent of physicians in PE-owned practices had been acquired in the prior five years, against about 10 percent in hospital-owned practices. Only 17.1 percent of physicians in PE-owned practices were acquired before 2015, compared with 47.2 percent in hospital-owned practices.

Most practices enter PE as an add-on, not a platform. Becker's ASC Review, reporting Private Equity Stakeholder Project (PESP) data, counted 148 deals involving outpatient care providers in calendar 2025. The count covers outpatient providers only and reflects PESP's own tracking, so it is not a total of all PE healthcare activity. Of those, 119 were add-ons, or 80.4 percent (our arithmetic: 119 ÷ 148). By subsector, dermatology led with 24 deals, eye care had 22 and oncology had 9.

How to use this in your search:

  1. Target platforms before funds. The fund sets strategy, but the platform's CEO and development team source and close add-ons in your specialty and region.
  2. Use announcements as a map. Every add-on press release names a platform, its sponsor and its geography. Ten announcements in your specialty give you a working buyer list. Track platform, sponsor, states, date and the platform's head of development.
  3. Pitch platform-scale businesses to funds directly. A practice large enough to anchor a new platform belongs in front of the fund's healthcare partners.
  4. Price the rollover, not just the headline. Add-on sellers usually roll equity into the platform. That stake is worth what the next buyer pays, less the platform's debt. Private Equity Physician Roll-Ups covers how the model pays each party.

Diligence on the Sponsor's Clock

Your rollover rides the platform's next exit, so find out where the platform sits in its life before you sign. The date the sponsor bought the platform does not tell you when it will sell. Ask for the facts directly.

Ask the sponsor Effect on your rollover
Which fund owns the platform, and what is that fund's vintage year and remaining term? An older fund has less time left to hold and more pressure to return capital
When did the sponsor acquire the platform, and what hold period did it underwrite? Shows whether your rollover is entering early or late in the plan
Is a sale, recapitalization or continuation vehicle planned or under discussion? A near-term exit can value your rollover before your practice has been integrated
If a continuation vehicle is used, can rollover holders choose to sell or roll again? Decides whether you get liquidity or another hold period
How much debt does the platform carry, and where does rollover equity rank? Platform debt is paid before your equity at the exit
Do rollover holders have tag-along rights and information rights? Decides whether you sell on the same terms as the sponsor and see results in the meantime

Ask two physicians who sold into the platform earlier how their rollover has been reported and valued since closing.

Worked Example: Control Sale vs Minority Recap

Simplified transaction model, hypothetical numbers, our arithmetic. The multiples are illustrative assumptions, not market data. The lower family office multiple reflects an assumed minority discount. All figures are gross of taxes, transaction fees and working capital adjustments.

Assumptions: - An orthopedic group with $2.5 million of EBITDA and $2.5 million of existing debt - PE control offer at 9.0x EBITDA for 100 percent. Debt is repaid from proceeds at closing. Owners roll 20 percent of equity value into the platform. - Family office minority offer at 7.0x EBITDA for 30 percent of the equity, bought from the owners. The debt stays on the practice.

PE control sale Family office minority recap
Enterprise value $2.5M × 9.0 = $22.5M $2.5M × 7.0 = $17.5M
Equity value (enterprise value less $2.5M debt) $20.0M $15.0M
Cash to owners at close 80% × $20.0M = $16.0M 30% × $15.0M = $4.5M
Equity owners keep $4.0M of platform equity (20% × $20.0M) 70% of the practice, $10.5M at the deal price
Debt remaining on the practice None (repaid at close) $2.5M
Who controls the next sale The sponsor The owners
What the retained stake depends on Platform performance, platform debt and the sponsor's exit Your own performance and exit timing

The PE offer pays $11.5 million more cash at close ($16.0M less $4.5M). The recap keeps $6.5 million more equity on paper ($10.5M less $4.0M) plus control. The retained $10.5 million is marked at a minority price. A later control sale would likely price higher. The right answer turns on how much cash the owners need now and whether they trust their own growth plan more than the platform's.

Family Offices: Match the Office's Structure to Your Deal

A single family office invests one family's capital. How it invests matters more than the label. An office writing direct checks from the family's balance sheet answers to no outside limited partners. That gives it room to hold a healthcare business for as long as the family chooses, take a minority stake or structure a partial recap a PE fund would decline. Room is not the same as appetite. Its own investment policy, committee and risk limits still decide what it will do. An office that invests through its own fund, an SPV with outside capital or co-investments alongside a sponsor takes on that vehicle's horizon and exit terms.

How the office invests Horizon Typical position Ask before the first meeting
Direct, from the family's balance sheet Set by the family's policy Minority or control Who makes the final decision, and which approvals sit between you and that person
Through its own fund or an SPV with outside investors The vehicle's term Follows the vehicle documents Fund or SPV term, target exit year, whether outside investors must approve
Co-investment alongside a PE sponsor The sponsor's hold Minority, behind the sponsor Which sponsors it backs, and whether it ever leads
Multi-family office Set by client mandates Varies by client Whether each client approves each deal

Healthcare depth varies as much as structure. Some offices employ former hospital executives and clinicians and hold several healthcare companies. Others have never underwritten a payer contract and rely on outside advisors. Qualify each office on five points:

Qualifier Strong signal Weak signal
How it invests Direct deals with a named decision-maker "We look at everything" with no closed healthcare deal to point to
Healthcare depth Operators or clinicians on staff, prior healthcare holdings Relies entirely on outside advisors
Position States plainly whether it takes minority stakes Asks for control late in the process
Check size Gives a range and says whether it leads or follows Will not name a range
Hold and exit Describes a hold period and an exit route it has used before No answer on how past deals ended

Approach your two or three best-matched offices first, with a complete data package, before the deal goes wide. An office that sees a deal after twenty others have passed asks why. How Family Offices Invest in Healthcare covers structures and sector preferences. The healthcare data room checklist lists what to have ready before the first call.

Strategic Buyers: 34.5 Percent of Physicians Work in Hospital-Owned Practices

Hospitals have absorbed most of the shift away from private practice. The figures below come from the AMA's 2024 report and reflect how surveyed physicians described their practice ownership. Point changes are our arithmetic.

Ownership measure (AMA survey) 2012 2024 Change
Physicians in private practice (wholly physician-owned) 60.1% 42.2% down 17.9 points
Physicians in hospital-owned practices 23.4% 34.5% up 11.1 points
Physicians employed by or contracted directly with a hospital 5.6% 12.2% more than doubled
Physicians with an ownership stake in their practice 53.2% 35.4% down 17.8 points

Hospital systems are also consolidating among themselves. Becker's Hospital Review, reporting Kaufman Hall data, reported in 2026 that hospital M&A was on pace for its busiest year since the pandemic, citing Kaufman Hall data. The pace can change from quarter to quarter. Check Kaufman Hall's latest quarterly report for current figures before relying on the trend. A system integrating its own merger may have little room for a physician group. Check your target's deal calendar before you open talks.

Strategics buy differently from financial investors:

Health plans and large multi-site provider groups also buy practices. Their reasons differ by buyer and by deal. Some want network coverage in a market, some want primary care capacity for value-based contracts and some want a specialty they currently pay others for. Ask each one what role your practice would play in its model and how your physicians would be paid in that role.

Venture Capital and Angels: Healthtech, Devices and Life Sciences

VC funds buy minority preferred equity in businesses that can grow many times over and exit through a sale or IPO within the fund's life. That covers care delivery software, digital health, devices, diagnostics and biotech. VC funds do not price a mature practice on EBITDA.

Stage Typical source What the investor needs to see
Pre-seed and seed Angels, physician angels, angel groups, some family offices Founding team, clinical problem, early prototype or pilot
Series A Healthcare-focused VC funds Early revenue or validated pilots, a defined buyer and payer
Growth Larger VC funds, crossover funds, corporate venture arms of health systems and payers Repeatable sales, reimbursement in place, unit economics

Healthcare VC diligence turns on four questions:

  1. Who pays? A patient, an employer, a health plan or a health system. Each has a different sales cycle and budget.
  2. What is the regulatory path? Devices and some clinical software need FDA clearance or approval before revenue starts, and investors price that time.
  3. Is there a reimbursement path? A product without a billing code depends on direct contracts or on savings it can prove.
  4. What clinical evidence exists? Health system buyers ask for outcomes data, and investors price the time it takes to produce it.

Read the term sheet beyond the valuation. Liquidation preferences, board composition and protective provisions decide who gets paid and who decides if the company underperforms. Corporate venture arms bring distribution as well as capital, and they tie you to one strategic before you have chosen an acquirer.

Physician Investors: Map Referrals Before You Take a Check

Physicians are a natural investor base for ASCs, imaging centers, real estate and de novo clinics. They understand the clinical case, and many want income beyond clinical pay. The Medscape Physician Compensation Report 2025 press release, covering 2024 pay, reports average physician compensation up 3.6 percent. The press release also says 47 percent of surveyed physicians felt fairly paid and about 40 percent were seeking paid work outside their primary roles. These figures come from the press release summary, not the full report. The survey measures pay pressure, not willingness to invest. Use it as context for the pitch.

Fewer physicians own a practice than a decade ago. The AMA's 2024 report puts owners at 35.4 percent, employees at 57.5 percent and independent contractors at 7.1 percent. Employed physicians can still invest, but many have never read an operating agreement. Budget time to explain the structure.

High-risk area: physician investors and referrals. Two sets of rules shape every physician raise. Referral laws can limit which physicians may own part of a business they send patients to. Securities rules govern how you find, approach and sell to investors. Either can change the structure, the investor list or the timeline. Take these questions to your own healthcare and securities attorney before any outreach:

  1. Which prospective investors refer patients to the business, and does that rule any of them out?
  2. How should distributions be set so they follow capital invested and not referral volume?
  3. Which offering path fits our outreach plan, and what does it allow us to say and to whom?
  4. What disclosures and investor qualifications does that path require?
  5. Do any states where we operate add their own limits on physician ownership?

Our Healthcare Compliance Due Diligence guide and Raising Capital from Physician Investors cover the background.

Practical steps that make a physician raise close cleanly:

Raising Capital from Physician Investors covers how physicians evaluate these deals. Capital Raising for Healthcare Companies covers offering mechanics.

Lenders: Price Debt Before You Sell Equity

Debt does not dilute ownership. Whether it costs less than equity depends on the full package, not the rate alone. Debt carries its own control. Covenants restrict distributions, acquisitions and further borrowing. Personal guarantees put owners' assets at risk. A breach hands the lender leverage over the business. The loan also has to be repaid or refinanced at maturity, on whatever terms the market offers then.

Compare across lenders What to ask for in writing
Capacity Maximum amount, whether it is sized on trailing, adjusted or projected cash flow, which add-backs count, and whether ramp losses at new sites reduce it
Price Rate, whether fixed or floating, upfront and unused-line fees, prepayment penalties
Covenants Leverage and coverage tests, how EBITDA is defined for them, how often they are tested
Guarantees and collateral Personal guarantees, spousal consent, liens on real estate or receivables
Amortization and maturity Interest-only period, repayment schedule, balloon at maturity
Refinancing risk What happens if rates rise or EBITDA falls before the loan must be refinanced
Lender type Typical fit
Bank Steady, documented cash flow, owners willing to guarantee
SBA 7(a) Smaller practices and acquisitions. The SBA 7(a) program is the SBA's main small business loan program
Private credit Acquisition plans and leverage levels banks decline, at higher cost
Asset-based lender Businesses with large receivables or equipment bases

Actual capacity, pricing and covenants come from each lender's underwriting of your numbers. Get at least two written term sheets before you compare debt with equity.

Worked Example: All Equity vs Debt Plus Equity

Simplified transaction model, hypothetical numbers, our arithmetic. A dermatology group has $3.0 million of EBITDA and needs $9.0 million to build four new sites.

Assumptions: - Pre-money enterprise value of 8.0x EBITDA, or $24.0 million. No existing debt, so pre-money equity value is also $24.0 million. - New capital is valued at par, so $9.0 million raised adds $9.0 million to enterprise value at closing - Senior debt at 9 percent, interest-only for three years. Fees, taxes and the tax deductibility of interest are ignored. - The four new sites lose a combined $1.0 million in year one while they ramp - Maintenance capex on existing sites is $0.3 million a year - All cash not spent on interest is distributed or retained pro rata to ownership, the same in both options

Option A: all equity Option B: senior debt plus family office equity
Senior debt $0 $6.0M (2.0x EBITDA)
New equity $9.0M $3.0M
Post-money equity value $24.0M + $9.0M = $33.0M $24.0M + $9.0M less $6.0M = $27.0M
Investor stake $9.0M ÷ $33.0M = 27.3% $3.0M ÷ $27.0M = 11.1%
Owners' stake 72.7% 88.9%
Owners' equity value at close 72.7% × $33.0M = $24.0M 88.9% × $27.0M = $24.0M
Annual interest $0 $6.0M × 9% = $540,000
Year-one cash before interest $3.0M less $1.0M less $0.3M = $1.7M $1.7M
Year-one interest coverage n/a $1.7M ÷ $0.54M = 3.1x

Both options leave the owners with $24.0 million of value on day one. Option B keeps 16.2 more points of ownership. The owners pay for those points with $540,000 a year of interest, covenants and risk. Coverage measured on EBITDA alone reads 5.6x ($3.0M ÷ $0.54M). Ramp losses and capex cut it to 3.1x. Lenders define coverage differently, on EBITDA, adjusted EBITDA, fixed charges or total debt service, so ask each lender which measure it tests and rerun the numbers on that definition.

Year three, debt still at $6.0 million, enterprise value at 8.0x EBITDA, our arithmetic:

Assumptions for the table: cash before interest rises in a straight line from $1.7 million in year one to year-three EBITDA less $0.3 million of capex, so year two is the midpoint of years one and three. All of it is distributed each year. Distributions are summed without discounting, taxes or fees. Option A's owners receive 72.7 percent of that cash. Option B's owners receive 88.9 percent of what is left after interest. Three years of interest totals $1.62 million ($540,000 × 3), and Option B's owners bear 88.9 percent of it, or $1.44 million. In return they take 16.2 more points of every dollar distributed.

Year-three enterprise value Owners' value, Option A Owners' value, Option B Option B ahead on equity value Three-year cash before interest Option B ahead on distributions Option B ahead in total
$36.0M (EBITDA $4.5M) 72.7% × $36.0M = $26.2M 88.9% × $30.0M = $26.7M $0.5M $1.7M + $2.95M + $4.2M = $8.85M roughly even (16.2% × $8.85M = $1.43M, less $1.44M) $0.5M
$48.0M (EBITDA $6.0M) 72.7% × $48.0M = $34.9M 88.9% × $42.0M = $37.3M $2.4M $1.7M + $3.7M + $5.7M = $11.1M $0.4M (16.2% × $11.1M = $1.80M, less $1.44M) $2.8M

Under these assumptions debt comes out ahead in both cases, but the margin depends on the new sites. At $4.5 million of EBITDA Option B is only $0.5 million ahead, a thin return for three years of covenants and guarantees. Loan fees, taxes and working capital needs, which this model leaves out, would narrow that gap further and could erase it. At $6.0 million it is $2.8 million ahead. If EBITDA stays flat at $3.0 million and cash before interest stays at $1.7 million a year, the same arithmetic puts Option B about $2.1 million behind.

Now stress year one. If core EBITDA falls by a third to $2.0 million, cash before interest drops to $0.7 million ($2.0M less $1.0M less $0.3M). Coverage falls to 1.3x ($0.7M ÷ $0.54M) and leverage on core EBITDA rises to 3.0x ($6.0M ÷ $2.0M). That combination can trip a covenant while the new sites are still losing money. Run this test, ramp losses included, before you choose. Healthcare Debt Financing compares bank, SBA, private credit and asset-based terms.

What Each Investor Will Ask For

Have the package ready before the first call. Gaps found in diligence cost price or time.

Item PE Family office Strategic VC Physician syndicate Lender
Three years of monthly financials Yes Yes Yes Revenue and burn Summary Yes
Quality of earnings report Common, varies with deal size Often Often Rarely Rarely For larger loans
Payer mix and top payer contracts Yes Yes Yes Reimbursement path Summary Yes
Provider roster, productivity and comp Yes Yes Yes Clinical team Yes Key-person detail
Compliance file (licensure, exclusion screening, billing audits) Yes Yes Yes Regulatory path Yes Yes
Growth plan with site-level economics Yes Yes Service line fit Market size and unit economics Project budget Debt service model
Referral map of investors n/a If physicians invest n/a If physicians invest Yes n/a

For staffing and wage assumptions in the growth plan, the BLS Health Care and Social Assistance industry page carries current official employment and wage data. Investors will check your hiring plan against it.

Before You Sign a Term Sheet: Comparing Offers on One Page

Offers arrive in different shapes: cash plus rollover, a minority price, a loan with covenants. Put every offer on one sheet before you negotiate any of them. The worked examples above show the method. The control sale and the minority recap look $5.0 million apart on enterprise value ($22.5M vs $17.5M), but $11.5 million apart on cash at close and $6.5 million apart the other way on retained equity.

Line on the comparison sheet What to enter What it tells you
Cash at close Equity value × share sold, less debt repaid, fees and escrows What you can actually spend or reinvest now
Retained equity and who controls it Rollover or remaining stake, and whose exit it rides on Whether your upside depends on your plan or a sponsor's
Debt left on the business Balance, rate, annual interest, covenants, guarantees, maturity The fixed cost and risk the retained equity carries
After-tax proceeds Your tax advisor's model of rollover, asset vs stock and earnout terms The number to compare, since structure changes net proceeds
Downside case Cash and coverage with core EBITDA down a third, as in the debt example Which offer still works if the year goes badly
Approvals to closing Every committee, consent and review the investor named at the first meeting A realistic closing date, not the hoped-for one
Fees to intermediaries Who is paid, how much and on what basis The true cost of the raise or sale

Work the sheet in this order:

The Deal Structure File: What to Assemble Before Offers Arrive

Structure questions slow a deal most when the facts behind them are scattered. Put these items in one file before the first term sheet. It lets your advisors answer quickly and lets you see which offers carry the most open questions.

File item What goes in it Offers it affects most
Ownership and entity chart Every entity, every owner and percentage, who holds clinical licenses, any management company already in place PE, family office, strategic
Referral map Each current and prospective physician investor, whether they refer, how often and for which services Physician syndicate, family office with physician co-investors, strategic
State footprint Every state with a site, a licensed clinician or a payer contract, plus planned expansion states PE, family office, strategic
Approvals log Every approval each investor named at the first meeting, with the person who signs All
Intermediary list Each person or firm promised a fee, the signed agreement and the BrokerCheck result All equity offers
Outreach record Everyone contacted about the raise, how they were reached and whether you knew them beforehand Physician syndicate, VC, family office
Tax model per offer Your tax advisor's after-tax proceeds for each structure on the comparison sheet PE, strategic, family office

Apply it to the control sale vs minority recap example. Both offers need the ownership chart and approvals log. The PE offer adds a rollover into a platform that may use a management services structure, so the file needs the platform's entity chart too. If the family office brings physician co-investors who refer to the group, the referral map moves to the front. An offer that needs three new file items late in the process is slower than its headline suggests, so score it that way on the comparison sheet.

Take the completed file to your own attorney. Healthcare Compliance Due Diligence, Management Services Organizations, the Healthcare M&A Process Guide and Capital Raising for Healthcare Companies cover how these items show up in diligence.

Building a 100-Name Investor List and Working It in Order

Sector knowledge beats list size. Former operators underwrite a healthcare business faster because they already understand reimbursement, staffing and compliance. Build from sources that show what investors have actually done:

Source What it gives you Who it finds
Add-on press releases in your specialty Platform, sponsor, geography, date PE platforms and their sponsors
PE firm and platform websites Current portfolio and target specialties PE funds and platforms
SEC EDGAR full-text search for Form D filings Healthcare companies in your region that raised private capital, with named executives and directors Founders and directors who have raised before
Hospital system disclosures on MSRB EMMA and system press releases Acquisitions, affiliations and service line plans of systems that issue municipal bonds Strategic buyers and their deal calendar
Subscription deal databases Deal history, check sizes and contacts PE, VC, family offices with recorded deals
Your own network and advisors Exited founders, former health system executives, physician angels Sector operators

Build the list in four tiers:

Tier Who Names Contact order
1. Best fit Direct-investing family offices with healthcare deals, PE platforms buying in your specialty and region, healthcare VC funds at your stage 5 to 10 First, with the full data package
2. Sector operators Exited healthcare founders, former health system executives, physician angels 20 to 30 After Tier 1 responds
3. Institutions PE funds, private credit lenders, health system corporate development and venture arms 30 to 40 In parallel with Tier 2
4. Physician syndicate Physicians you know personally, screened for referral relationships Remainder Last, once the structure is settled

Run reverse diligence on every Tier 1 name before the first meeting. Ask for two founder references, including one where the deal went badly. Reverse Due Diligence on Healthcare Investors lists the questions.

The first message must show fit in its opening lines. Include five items:

Track every name in one sheet: tier, date contacted, response, next step and reason for any pass. Pass reasons are the most useful data you will collect. Three passes for the same reason, such as size, payer mix or a missing QoE, tell you what to fix before you open the next tier.

Questions owners ask

Which type of healthcare investor moves fastest?

The number of approval layers sets the pace more than the investor type. At the first meeting, ask each investor to name every approval between the first call and a signed term sheet, and who signs at each step. PE funds and hospital systems often add a quality of earnings report, committee approval or integration planning, depending on the buyer and the deal size. A lender can move quickly when cash flow is steady and documented. A family office can be quick or slow depending on its own governance, so ask rather than assume.

Can I raise money from physicians who refer patients to my business?

Sometimes. The answer depends on the structure and the facts. Referral laws can apply when a physician who refers patients to a business also owns part of it. Build a referral map of every prospective physician investor and settle the structure before anyone commits money.

Do family offices take minority stakes in healthcare companies?

Many do, but each office sets its own mandate. An office investing from the family's balance sheet is free to take a minority stake or hold for a long time, though its own policies may rule that out. An office investing through a fund, an SPV or alongside a PE sponsor takes on that vehicle's horizon and exit terms. Find out how the office invests and what it has done before you send a deck.

Should I sell control or a minority stake?

Compare cash at close against what you keep and who controls the next sale. A control sale to PE usually pays more cash today, but your rollover depends on the platform's exit. A minority recap pays less cash and leaves you in control of the remaining equity. The worked example in this guide runs both on the same business.

Do venture capital firms invest in medical practices?

Rarely. Venture capital backs healthtech, device, diagnostics and biotech companies that can grow many times over and exit through a sale or IPO. A cash-flowing practice is valued on EBITDA and fits PE, family offices, strategics or lenders. A technology business built around a practice can fit VC if the growth case is real.

How many investors should be on my outreach list?

Build the list around fit, not volume. About 100 names with a real sector connection, drawn from add-on announcements, Form D filings, hospital system disclosures and exited healthcare founders, beats a purchased database of thousands. Rank the list in tiers and contact the best-matched investors first.

Sources